|
|
 |
|
THOR: Thoratec Cp - Stock News |
Enter Ticker:
|
|
| Nov 24, 2009 |
Thoratec Presentation at Piper Jaffray Conference to be Webcast |
| Nov 17, 2009 |
Destination Therapy Trial Data Demonstrate Superiority for HeartMate II(R) Over HeartMate(R) XVE |
| Nov 17, 2009 |
Destination Therapy Trial Data Demonstrate Superiority for HeartMate II(R) Over HeartMate(R) XVE |
| Nov 17, 2009 |
TheFortuneFinancial.com Progressive Review on SNDK, STEC, COST, THOR,ENER and MBFI |
| Nov 12, 2009 |
Thoratec Investor Meeting to Review HeartMate II (R) Destination Therapy Trial Data to Be Webcast |
| Nov 09, 2009 |
Thoratec Presentation at Canaccord Adams Conference to be Webcast |
| Nov 06, 2009 |
RothmanResearch.com Equity Review for THOR, NFLX, AMMD, TRMB, EGLEand CTAS |
| Nov 04, 2009 |
Thoratec Raises Guidance, but Remains In-line with Estimates |
| Nov 04, 2009 |
Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent |
| Nov 04, 2009 |
Conference Calls Today: 4:30 P.M. EDT |
| Nov 02, 2009 |
BUYINS.NET: AEO, ATW, TSL, CECO, THOR, AWH Expected To Be Lower Leading Up To Next Earnings Releases |
| Oct 28, 2009 |
Thoratec (THOR) Bearish Technical Alert - Trend Down 3.8% |
| Oct 27, 2009 |
Thoratec Schedules Third Quarter Conference Call, Webcast |
| Oct 19, 2009 |
RidgewaterEquity.com Free Fundamental Sector & Market Research onTHOR, VNDA, SIGM, ETRM, TXRH and NFLX |
| Oct 09, 2009 |
Thoratec Up 10.5% Since SmarTrend's Buy Recommendation |
| |
| ZACKS COMMENTARY FOR THOR |
|
|
|
Sponsored Links 
-0.12